NCT05100147

Brief Summary

Cesarean operations are one of the most common obsetric operations and have an increasing trend in all over the world. However unfortunately the operation techniques have not been standardized yet. It is well known that different uterine closure techniques result in differences with respect to wound healing on the uterus; however, the ideal uterine closure technique is yet not known. The aim of this study is to assess the results of different uterine closure techniques during cesarean section with respect to the development of cesarean scar defects.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
43

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Nov 2021

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 15, 2021

Completed
14 days until next milestone

First Posted

Study publicly available on registry

October 29, 2021

Completed
3 days until next milestone

Study Start

First participant enrolled

November 1, 2021

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 31, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 31, 2022

Completed
Last Updated

October 31, 2023

Status Verified

October 1, 2023

Enrollment Period

7 months

First QC Date

October 15, 2021

Last Update Submit

October 28, 2023

Conditions

Keywords

cesarean scar defectcesarean sectionuterine closure techniques

Outcome Measures

Primary Outcomes (2)

  • Scar thickness at postpartum 6th week

    The patients will be examined at the postpartum sixth week. During that visit uterine scar thickness will be measured by ultrasound. Measurement of uterine scar thickness will be performed perpendicular to the uterine wall and calipers will be placed on the serosal surface of the uterus and the delineation of the endometrium. These landmarks represent the inner and outer edge of the Cesarean scar.

    Postpartum 6th weeks

  • Scar thickness at postpartum 6th month

    The patients will be reexamined at the postpartum sixth month. During that visit uterine scar thickness will be measured again. Measurement of uterine scar thickness will be performed with the same method (perpendicular to the uterine wall and calipers will be placed on the serosal surface of the uterus and the delineation of the endometrium. These landmarks represent the inner and outer edge of the Cesarean scar.)

    Postpartum 6th months

Study Arms (3)

Group 1

EXPERIMENTAL

The uterotomy suture technique is continous, double layer suturing, in which the first layer is continuous and unlocked involving all uterine layers and a second, continuous non-locking imbrictating layer is applied over the first suture.

Procedure: Uterine closure during Cesarean section

Group 2

EXPERIMENTAL

The uterotomy suture technique is continous, double layer suturing, in which the first layer is continuous and unlocked not including decidua and a second, continuous non-locking imbrictating layer is applied over the first suture.

Procedure: Uterine closure during Cesarean section

Group 3

EXPERIMENTAL

The uterotomy suture technique is continous ,double layer with the first layer unlocked, excluding the decidua and including the deep part of the myometrium, and the second layer unlocked including the remaining part of the myometrium.

Procedure: Uterine closure during Cesarean section

Interventions

The uterotomy is sutured after the delivery of the fetus and the placenta with an appropriate delayed absorbable suture (number 1 polyglactin 910)

Group 1Group 2Group 3

Eligibility Criteria

Age18 Years - 40 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • being nulliparous
  • having singleton fetus
  • not having diabetes and or hypertension
  • not having an intrauterine infection
  • body mass index \<35 kg/m2
  • not having any placental insertion anomalies
  • not having Mullerian anomalies
  • active phase of labor is not started.
  • no previous uterine surgeries

You may not qualify if:

  • being multiparous
  • having multiple pregnancies
  • having diabetes and or hypertension
  • having an intrauterine infection
  • body mass index \>=35 kg/m2
  • having any placental insertion anomalies
  • having Mullerian anomalies
  • in active phase of labor
  • having previous uterine surgeries

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Mersin University Hospital

Mersin, 33170, Turkey (Türkiye)

Location

MeSH Terms

Conditions

CicatrixCongenital Abnormalities

Condition Hierarchy (Ancestors)

FibrosisPathologic ProcessesPathological Conditions, Signs and SymptomsCongenital, Hereditary, and Neonatal Diseases and Abnormalities

Study Officials

  • Ezgi Oktay, MD

    Mersin University Hospital

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Prof. Dr. Hakan Aytan

Study Record Dates

First Submitted

October 15, 2021

First Posted

October 29, 2021

Study Start

November 1, 2021

Primary Completion

May 31, 2022

Study Completion

May 31, 2022

Last Updated

October 31, 2023

Record last verified: 2023-10

Data Sharing

IPD Sharing
Will not share

Locations